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THE INCREASING INCIDENCE OF
BLINDNESS DUE TO RETINOPATHY
OF PREMATURITY
Retinopathy of prematurity (ROP) is a
major cause of potentially avoidable blind-
ness in children in the middle-income
countries of Latin America and Eastern
Europe, and is becoming a public health
problem in Asia.1 Indeed, the earlier esti-
mate that there were 50 000–60 000 chil-
dren worldwide who were blind from
ROP2 is a marked underestimate, as a
recent systematic review suggests that
annually 20 000 infants (uncertainty
range 15 500–27 200) became blind or
severely visually impairment from ROP
worldwide in 2010, with a further 12 300
(8300–18 400) being visually impaired.3
Asia has the highest number, reﬂecting the
rapid expansion of services for preterm
infants in the region.4 5 The rate of severe
visual loss from ROP is 1.8–2.6 times
higher per million births in East Asia, the
Paciﬁc region, Latin America and Eastern
Europe than in high-income countries,
reﬂecting both a higher incidence of
severe ROP and inadequate detection and
treatment.
The recognition that prematurity is a
major cause of infant and under ﬁve mor-
tality rates6 is leading to rapid expansion
of neonatal care in many countries such as
India,7 China and Russia, which will put
an increasing number of infants at risk
of ROP. Visual loss from ROP will con-
tinue to increase in low-income and
middle-income countries with improving
preterm survival rates unless there are
dramatic improvements in neonatal care
coupled with higher coverage of high-
quality services for the detection and
treatment of ROP.
PROGRAMMES FOR ROP IN
LOW-INCOME AND MIDDLE-INCOME
COUNTRIES
The vast majority of programmes for the
detection and treatment of ROP rely on
highly skilled ophthalmologists who visit
neonatal units on a weekly basis, or more
frequently, to examine infants at risk.
Many middle-income countries have cri-
teria for examination, often drawn up col-
laboratively by professional societies of
ophthalmologists and neonatologists, and
programmes are becoming integrated into
health systems. Many use criteria based
on local evidence of the population of
infants at risk, which in many resource-
poor settings includes more mature
infants than those examined in the UK,
for example, those with birth weights
(BWs) in the range 1500–2000 g or gesta-
tional ages (GA) above 31 weeks.8 9
FAILURE OF ROP PROGRAMMES
Taking a programmatic perspective, there
are many reasons why infants may
become blind from ROP. First, infants may
have received care in a unit without ser-
vices for the detection and/or treatment of
ROP. Second, infants with BWs and GAs
that exceed criteria for examination, but
who fall within ‘sickness criteria’, may not
be examined, as these criteria are usually
not clearly deﬁned or straightforward to
apply. Third, the infant may have been
identiﬁed as requiring examination, but
this was not carried out effectively, that is,
the interval between examinations was too
long, or the signs of ROP were not
adequately determined or interpreted, or
the infant was deemed too sick for exam-
ination. Administrative errors or poor
communication can also lead to failure of
examination after discharge or transfer
between neonatal units. Inadequate com-
munication with parents or parents who
lack the resources to travel back to the
unit on the requisite day after discharge
may also result in failure to detect ROP
needing treatment. Lastly, ROP requiring
treatment may have been detected, but the
treatment was not successful (eg, laser
treatment was inadequate, or the infant
had rapidly progressing disease, which did
not respond to adequate treatment), or
treatment was not given, or was delayed
because of lack of anaesthesia, skilled per-
sonnel or equipment, or the infant was
too sick. All these different reasons have
been cited.10–14 Indeed, a recent study of
48 infants who presented with stage 5
ROP to an eye department in a major city
in Mexico over a 2-year period revealed
that 50% had been cared for in a unit
without an ROP programme. Among the
24 infants who were cared for in units
with a programme, 15% of mothers
reported that their infant had not been
examined, and 19% of infants were either
not referred for examination after dis-
charge, or they did not attend.10 This is
despite Mexico having national guidelines
for ROP and legislation making eye
examination of all preterm infants man-
datory. In a further study in Mexico
involving 32 units in ﬁve major cities,
34% of units had no programme for the
detection and treatment of ROP, and only
31% of programmes entailed regular visits
by an ophthalmologist, with laser treat-
ment being provided in the unit if
indicated.15
In many middle-income countries,
there is a complex interplay of economic,
political and personal reasons why ser-
vices for the detection and treatment of
ROP are not in place in all neonatal units.
Some ministries of health are not aware of
the serious, potentially avoidable compli-
cations of preterm birth, and so, policies
are not in place to address them, or they
face competing demands and prioritise
life-threatening conditions. Other coun-
tries have highly complex health systems
with multiple providers and insurance
schemes, which make implementing
uniform policies and practices very chal-
lenging. Studies highlight the challenges
of ophthalmologist-led programmes,
which include long distances between
units, fear of litigation, lack of time or
interest in taking on ROP and lack of
ﬁnancial remuneration, some of which
also apply to high-income settings.16
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Programmes that use regular retinal
imaging with or without remote interpret-
ation of images have the potential to
increase coverage, but any approach that
relies on visits by personnel external to
the neonatal service, such as ophthalmolo-
gists, can only address some of the pro-
blems. An additional important factor is
that there is currently only one wide-ﬁeld
retinal camera suitable for ROP (RetCam,
Clarity), which is very expensive. In order
to address the rapidly expanding popula-
tion of babies at risk of ROP and the chal-
lenges faced by health providers (neonatal
care and eye care) and parents, a paradigm
shift in the detection of acute ROP
needing treatment is required, which uses
screening in the true sense of the word.
This would require new, low cost, wide-
ﬁeld imaging technology, as visualisation
of the peripheral retinal vasculature is
essential for making the management
decision that no further retinal examina-
tions are required, which is not yet avail-
able. But ﬁrst, consideration of the term
screening is required.
SCREENING FOR ROP
Screening is deﬁned as ‘a process of iden-
tifying apparently healthy people who
may be at increased risk of the disease or
the condition [of interest]. They can then
be offered information, further tests and
appropriate treatment to reduce their risk
and/or any complications arising from the
disease or condition’.17 A screening pro-
gramme requires a simple, valid, non-
invasive, acceptable and inexpensive test,
which is applied to the population at risk.
Those who fail the screening test require
clinical assessment to conﬁrm the diagno-
sis, followed by treatment if indicated.
Another requirement of screening pro-
grammes is that earlier treatment of the
condition leads to better outcomes.
Ophthalmology-led programmes for ROP
are not, therefore, screening programmes
in the strict sense of the word as diagnos-
tic examinations are performed with clin-
ical decisions at each visit (ﬁgure 1).
Screening for ROP requiring treatment
differs from screening for chronic diseases
such as breast, cervical or prostate cancer
or diabetic retinopathy, or screening for
metabolic disorders where a one-off test is
required. First, the population at risk is
deﬁned by BW, GA and the services
received (ie, neonatal care) and not by
chronological age, gender or disease status
(eg, diabetes). Second, there is a very
narrow time interval during which severe
ROP develops (ie, from 3 to 18 weeks
after birth depending on GA). Third,
there is not a simple pass/fail test as each
assessment requires a management deci-
sion, which has three options: (1) no
further examination is required as the
retinal vessels are mature or ROP is deﬁn-
itely regressing, or (2) further examination
is required after an interval to be decided
by the screener (3–4 days or up to
2 weeks), or (3) treatment is required,
which should be given within 48 h.
THE PARADIGM CHANGE REQUIRED
Given the challenges and limitations of
current programmes, there is an urgent
need for a change in approach, which will
become possible in the foreseeable future
as low-cost high-quality imaging systems
suitable for ROP become available (ie,
with a wide ﬁeld of view). Indeed, several
groups are developing wide-ﬁeld imaging
systems suitable for ROP screening.
Ideally, each unit would have its own
imaging system, which would allow a
neonatology-led approach to screening for
ROP (ﬁgure 1). Ideally, a member of the
clinical neonatal team or a trained techni-
cian would take and interpret images
immediately at the cot-side. Only those
infants with clearly deﬁned indications
would be referred for an urgent ophthal-
mic opinion. Putting the responsibility for
screening in the hands of the neonatal
team has considerable advantages as
infants can be screened at a time that is
convenient and when infants return for
follow-up after discharge regardless of the
day of the week. Immediate, on-site inter-
pretation would also be highly desirable,
so mothers of discharged infants can be
given the management decision straight
away. Immediate interpretation also does
not require fast internet connections for
remote interpretation, which is particu-
larly important in low-income and
middle-income settings where mothers of
preterm infants may live many hundreds
of miles away from the unit, and where
many mothers are relatively uneducated,
unmarried, uninformed and/or are
teenagers.
The utility of this approach is sup-
ported by a multicentre study in the
USA18 where trained non-physician
readers demonstrated high levels of valid-
ity in detecting ‘referral-warranted ROP’
(as deﬁned by Ells)19 by remote viewing
of digital images obtained by non-
physician imagers. Others have also
demonstrated that neonatal nurses can
reliably capture images.20 In a large-scale
programme in India, trained non-medical
technicians visit neonatal units on a
weekly basis where they take and interpret
the images, only sending images for
remote interpretation by experts when
they suspect referral-warranted ROP. The
role of non-ophthalmologists in screening
has been advocated by Trese,21 and the
Indian programme has demonstrated that
technicians can also achieve high levels
of validity.22 Both studies indicate the
potential role of imaging by non-
ophthalmologists in increasing the cover-
age of screening for ROP regardless of the
setting. Indeed, the authors of a recent
joint report from the American Academy
of Pediatrics Section on Ophthalmology,
the American Academy of Ophthalmology
and the American Association of Certiﬁed
Orthoptists support the role of telemedi-
cine with remote image analysis in surveil-
lance for referral-warranted ROP.23
There are further advantages of
neonatology-led screening, as ophthalmol-
ogists would only need to visit units to
examine the relatively small number of
infants developing severe ROP. This is
likely to increase the number of ophthal-
mologists willing to provide services for
ROP and greatly reduces their costs, so
improving cost-effectiveness. There would
be advantages for parents of discharged
infants as they would not have to bring
their child back to coincide with the visit
by the ophthalmologist. Images can also
be used to train staff and to raise aware-
ness among parents. A permanent record
of the retina also allows progression or
regression of disease to be more readily
detected, and can be used for medicolegal
purposes. Automatic image analysis
systems are being developed, which have





There are several important factors to
consider in establishing a neonatology-led
programme. First, a change in mindset
will be required among neonatologists
and ophthalmologists, and clearly deﬁned
roles and responsibilities will need to be
established, recognising that close collab-
oration and clear lines of communication
between neonatologists and ophthalmolo-
gists will continue to be essential.
Personnel, be they medical, paramedical
or technicians, will need to be trained to
reach high levels of competency and
maintain this level through quality assur-
ance measures. In the Indian programme
outlined above, Vinekar has developed
competency-based training for the techni-
cians, delineating the skills required across
a range of activities: the technicians can
only make independent management deci-
sions once they have reached the highest
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level of competency.22 More than one
person per unit will need to be trained to
cover annual leave, illness and personnel
changes.
Ophthalmologists with skills in diagnos-
ing and treating ROP will still be required,
with clear indications concerning which
neonatal units they will be responsible for.
Advocacy with ministries of health will be
required for policy change so that any
new retinal imaging system becomes
essential equipment for neonatal intensive
care, and additional staff may also be
required. The medicolegal implications of
screening by non-ophthalmologists will
also have to be addressed, as will
licensing.
Screening and treating ROP is highly
cost-effective. The incremental cost of a
neonatology-led service may be lower than
that estimated for the ophthalmology-led
service in Brazilian Government’s munici-
pal health service for neonatal care where
the cost for ophthalmologists to visit and
examine all eligible infants for ROP would
increase the cost of providing neonatal
care by 10%.25
Some lessons can be learnt from
clinician-led echocardiography (using
Doppler sonography), which has become
more readily available since the develop-
ment of affordable equipment. However,
the situation is not entirely parallel to
neonatology-led screening for ROP as
echocardiography is not used to screen
for cardiac abnormalities, but as an
adjunct to clinical diagnosis and to
monitor treatment.26 Echocardiography is
now often performed by neonatologists or
paediatricians rather than by paediatric
cardiologists or radiologists. However,
several issues have arisen, some of
which have hindered more widespread
adoption of clinician-led echocardiog-
raphy. The main issues relate to profes-
sional boundaries, the nature and content
of competency-based training,27 medicole-
gal issues and remuneration. Another
issue that remains controversial is the lack
of robust evidence from clinical trials of
the impact of clinician-led echocardiog-
raphy.28 However, some argue that clin-
ical trials are not required to assess the
effectiveness of echocardiography as the
main question is diagnostic accuracy.
In neonatology-led screening for ROP,
competency-based training would be
required, recognising that acquiring new
skills and capabilities requires experience
and supervision. The indications for refer-
ral for an ophthalmic opinion devised by
Ells19 may also need to be simpliﬁed. In
terms of diagnostic accuracy, studies
would be needed to compare the accuracy
of interpretation of retinal images by a
member of the neonatal team compared
with the gold standard, that is, indirect
ophthalmoscopy by an ophthalmologist
with experience in ROP. In these studies,
it will be important to assess the validity
of the management decisions as well as
the validity of the clinical signs of ROP
elicited. Medicolegal issues would need to
be addressed by clearly deﬁning where the
burden of responsibilities lies from initial
identiﬁcation of infants at risk through to
timely treatment of severe disease.
Difﬁculties in relation to professional
boundaries may arise, but one of the main
challenges, which limits increase in cover-
age of programmes for the detection of
severe ROP, is the lack of ophthalmolo-
gists with the relevant expertise, interest
or time to visit neonatal units on a regular
basis. Close collaboration between the
team on the neonatal unit and ophthal-
mologists will continue to be vital to the
control of visual loss from ROP.
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